C4 Therapeutics, Inc.
CCCC- 交易所
- Nasdaq
- 產業
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001662579
近 90 天，C4 Therapeutics, Inc. 沒有內部人公開市場買賣的申報；2026 年第 2 季末有 148 家機構在 13F 申報持有，市值合計 $5.48 億；沒有大師持有。
SEC 申報
C4 Therapeutics, Inc. 向 SEC 申報的 10-K、10-Q、8-K、20-F、40-F，最新的在前。
Livermore 只列出每份申報的表單、8-K 的 Item 與日期。內文請到 SEC 網站讀；8-K 的新聞稿等附件（例如 Item 2.02 的 EX-99.1）在申報目錄裡。
| 申報日 | 表單 | 8-K 的 Item | 期間 | 原文 | 申報目錄 |
|---|---|---|---|---|---|
| 2026/11/5 | 10-Q | – | 2026/9/30 | SEC | 目錄 |
| 2026/11/5 | 8-K | 2.029.01 | 2026/11/5 | SEC | 目錄 |
| 2026/9/25 | 8-K | 7.018.019.01 | 2026/9/25 | SEC | 目錄 |
| 2026/8/11 | 10-Q | – | 2026/6/30 | SEC | 目錄 |
| 2026/8/11 | 8-K | 2.029.01 | 2026/8/11 | SEC | 目錄 |
| 2026/6/24 | 8-K | 5.079.01 | 2026/6/24 | SEC | 目錄 |
| 2026/6/11 | 8-K | 7.018.019.01 | 2026/6/11 | SEC | 目錄 |
| 2026/5/15 | 8-K | 5.02 | 2026/5/15 | SEC | 目錄 |
| 2026/5/12 | 10-Q | – | 2026/3/31 | SEC | 目錄 |
| 2026/5/12 | 8-K | 2.027.019.01 | 2026/5/12 | SEC | 目錄 |
| 2026/4/10 | 8-K | 5.039.01 | 2026/4/10 | SEC | 目錄 |
| 2026/4/9 | 8-K | 1.017.019.01 | 2026/4/9 | SEC | 目錄 |
| 2026/2/26 | 10-K | – | 2025/12/31 | SEC | 目錄 |
| 2026/2/26 | 8-K | 2.029.01 | 2026/2/26 | SEC | 目錄 |
| 2026/1/14 | 8-K | 7.019.01 | 2026/1/14 | SEC | 目錄 |
| 2025/11/6 | 10-Q | – | 2025/9/30 | SEC | 目錄 |
| 2025/11/6 | 8-K | 2.029.01 | 2025/11/6 | SEC | 目錄 |
| 2025/10/16 | 8-K | 8.01 | 2025/10/16 | SEC | 目錄 |
| 2025/10/16 | 8-K | 1.019.01 | 2025/10/16 | SEC | 目錄 |
| 2025/10/1 | 8-K | 7.018.019.01 | 2025/10/1 | SEC | 目錄 |
| 2025/9/22 | 8-K | 7.018.019.01 | 2025/9/22 | SEC | 目錄 |
| 2025/8/7 | 10-Q | – | 2025/6/30 | SEC | 目錄 |
| 2025/8/7 | 8-K | 2.027.018.019.01 | 2025/8/7 | SEC | 目錄 |
| 2025/6/18 | 8-K | 5.035.079.01 | 2025/6/18 | SEC | 目錄 |
| 2025/5/7 | 10-Q | – | 2025/3/31 | SEC | 目錄 |
| 2025/5/7 | 8-K | 2.027.018.019.01 | 2025/5/7 | SEC | 目錄 |
| 2025/4/14 | 8-K | 5.02 | 2025/4/14 | SEC | 目錄 |
| 2025/2/27 | 10-K | – | 2024/12/31 | SEC | 目錄 |
| 2025/2/27 | 8-K | 2.029.01 | 2025/2/27 | SEC | 目錄 |
| 2025/1/14 | 8-K | 2.027.01 | 2025/1/14 | SEC | 目錄 |
| 2024/12/9 | 8-K | 8.019.01 | 2024/12/9 | SEC | 目錄 |
| 2024/11/20 | 8-K | 5.027.019.01 | 2024/11/20 | SEC | 目錄 |
| 2024/10/31 | 10-Q | – | 2024/9/30 | SEC | 目錄 |
| 2024/10/31 | 8-K | 2.029.01 | 2024/10/31 | SEC | 目錄 |
| 2024/10/16 | 8-K/A | 5.027.019.01 | 2024/10/15 | SEC | 目錄 |
| 2024/10/15 | 8-K | 5.027.019.01 | 2024/10/15 | SEC | 目錄 |
| 2024/10/11 | 8-K | 5.029.01 | 2024/10/11 | SEC | 目錄 |
| 2024/9/3 | 8-K | 5.027.019.01 | 2024/9/3 | SEC | 目錄 |
| 2024/8/1 | 10-Q | – | 2024/6/30 | SEC | 目錄 |
| 2024/8/1 | 8-K | 2.02 | 2024/8/1 | SEC | 目錄 |
| 2024/6/21 | 8-K | 5.07 | 2024/6/21 | SEC | 目錄 |
| 2024/6/10 | 8-K | 5.027.019.01 | 2024/6/10 | SEC | 目錄 |
| 2024/5/8 | 10-Q | – | 2024/3/31 | SEC | 目錄 |
| 2024/5/8 | 8-K | 2.029.01 | 2024/5/8 | SEC | 目錄 |
| 2024/3/8 | 8-K | 5.02 | 2024/3/8 | SEC | 目錄 |
| 2024/3/4 | 8-K | 1.017.019.01 | 2024/3/4 | SEC | 目錄 |
| 2024/2/22 | 10-K | – | 2023/12/31 | SEC | 目錄 |
| 2024/2/22 | 8-K | 2.029.01 | 2024/2/22 | SEC | 目錄 |
| 2024/1/11 | 8-K | 7.019.01 | 2024/1/11 | SEC | 目錄 |
| 2024/1/9 | 8-K | 2.057.019.01 | 2024/1/9 | SEC | 目錄 |